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Introduction {#sec1}
============

Lysosomes are classically viewed as degradative organelles ([@bib32]). Several studies, however, have demonstrated that lysosomes, along with other related acidic organelles, comprise additional sources of intracellular Ca^2+^. Notably, these sources are distinct from the endoplasmic reticulum (ER) and mitochondria ([@bib18]). In this paper, we use the term lysosome to collectively refer to the lysosome and its related acidic organelles.

Ca^2+^ signaling from lysosomes has now been described in a number of cell types ([@bib19], [@bib18]). Ca^2+^ storage in the lysosome requires an H^+^ gradient, which is generated by a vacuolar H^+^-ATPase (V-ATPase), and some form of Ca^2+^/H^+^ exchange ([@bib40]). Ca^2+^ release from the lysosomes requires the second messenger nicotinic acid adenine dinucleotide phosphate (NAADP), which is synthesized, most likely by ADP-ribosyl cyclases, in response to cell-specific physiological stimuli ([@bib19], [@bib18]). NAADP-dependent Ca^2+^ efflux from lysosomes is thought to occur either via transient receptor potential cation channels of the mucolipin 1 family (TRPML1) or via two-pore channels (TPC1/TPC2) ([@bib22]), with the weight of evidence currently suggesting that NAADP acts via TPCs, most likely via an NAADP-associated binding protein ([@bib39], [@bib43]).

NAADP-dependent lysosomal Ca^2+^ signaling is likely to play a role in neurons. NAADP binding sites have been found throughout the brain ([@bib49]), and NAADP synthesis and lysosomal Ca^2+^ release in neurons can be triggered by exogenous stimulation with glutamate ([@bib48]). Moreover, application of NAADP elicits Ca^2+^ release in brain microsomes ([@bib2]), promotes neuronal differentiation in PC12 cells ([@bib7]), augments neurite outgrowth in developing cortical neurons ([@bib6]), drives membrane depolarization in medullary neurons ([@bib8]), and increases Ca^2+^ influx through N-type voltage-gated Ca^2+^ channels (VGCCs) in cultured hippocampal neurons ([@bib25]). Lysosomes have also been found in axonal boutons, and pharmacologically induced Ca^2+^ release from these organelles can drive spontaneous neurotransmitter release ([@bib5], [@bib36]). Lysosomal Ca^2+^ release, however, has not been investigated in postsynaptic structures or in the context of synaptic plasticity.

In addition to mediating Ca^2+^ signaling, the lysosome itself can also undergo Ca^2+^-dependent fusion, both with other organelles and with the plasma membrane ([@bib32]). In the latter case, lysosomal exocytosis can be important in some cell types for the secretion of chemical signals or enzymes ([@bib4], [@bib66], [@bib19], [@bib13], [@bib18]) or for promoting lipid turnover and facilitating membrane growth and repair ([@bib56], [@bib4], [@bib32]). Although not well studied, lysosomal fusion has been reported in developing hippocampal and sympathetic neuronal cultures, where it regulates the surface expression of N-type VGCCs and the outgrowth of neurites, respectively ([@bib1], [@bib25]). However, it is not clear what physiological trigger drives lysosomes to fuse with the plasma membrane or the significance of this fusion for information processing in neurons.

Here we examined the role of lysosomes in hippocampal pyramidal neurons. We found that lysosomal Ca^2+^ signaling and lysosomal fusion with the plasma membrane were driven by back-propagating action potentials (bpAPs) and were necessary for the long-term structural plasticity of dendritic spines.

Results {#sec2}
=======

Lysosomes Contribute to bpAP-Evoked Dendritic Ca^2+^ Signaling {#sec2.1}
--------------------------------------------------------------

We began by examining the distribution of lysosomes in hippocampal pyramidal neurons. To do so, we incubated hippocampal slice cultures with LysoTracker red (50 nM, 40--60 min), a fluorescent dye that preferentially labels lysosomal compartments ([@bib11]). We found LysoTracker-labeled puncta throughout the dendritic arbor of CA3 and CA1 neurons and in some dendritic spines ([Figure 1](#fig1){ref-type="fig"}A). To confirm that LysoTracker fluorescence was specific for lysosomes, we used glycyl-L-phenylalanine 2-naphthylamide (GPN, 200 μM, 5--10 min) to selectively disrupt lysosomal compartments. GPN is a cell-permeable substrate for the lysosome-specific enzyme Cathepsin C. When cleaved, GPN becomes membrane-impermeable and exerts an osmotic effect that disrupts the lysosomal membrane, leading to the leakage of small molecules out of the organelle ([@bib51]). We found that addition of GPN abolished the vast majority of LysoTracker fluorescence in cells (n = 5 cells; Mann-Whitney test, p \< 0.01; [Figure 1](#fig1){ref-type="fig"}B), suggesting that LysoTracker was predominantly labeling lysosomal compartments. Notably, GPN-induced disruption of the lysosomal membrane was not accompanied by any detrimental effects on neuronal morphology ([Figure 1](#fig1){ref-type="fig"}A), resting membrane potential, conductance, and intracellular pH ([Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}).

We next examined whether lysosomes contributed to dendritic Ca^2+^ signaling during neuronal activity. We loaded CA3 and CA1 neurons with the Ca^2+^-sensitive dye Oregon Green BAPTA-1 (OGB-1) and imaged dendritic Ca^2+^ in response to single bpAPs ([Figure 1](#fig1){ref-type="fig"}C). bpAP-evoked Ca^2+^ influx is thought to be predominantly, if not exclusively, mediated by VGCCs ([@bib26], [@bib12], [@bib61], [@bib23]). However, we found that GPN, despite having no effect on the action potential waveform ([Figure S1](#mmc1){ref-type="supplementary-material"}), significantly reduced the Ca^2+^ rise evoked by a single bpAP (in %ΔF/F; artificial cerebrospinal fluid \[ACSF\], 153 ± 11; GPN, 103 ± 10; n = 18 cells; post hoc Dunn's test, p \< 0.01; [Figures 1](#fig1){ref-type="fig"}C--1E); these reductions were found throughout the dendritic arbor ([Figure 1](#fig1){ref-type="fig"}D) and were also present in acute hippocampal slices (n = 6 cells; post hoc Dunn's test, p \< 0.05; [Figures 2](#fig2){ref-type="fig"}E and 2F). In contrast, application of vehicle control (DMSO) alone had no effect on bpAP-evoked Ca^2+^ transients (n = 7 cells; post hoc Dunn's test, p = 0.99; [Figure 1](#fig1){ref-type="fig"}E).

Lysosomal Ca^2+^ Release Requires NAADP {#sec2.2}
---------------------------------------

To confirm that neuronal activity could trigger Ca^2+^ release from the lysosomes, we used additional means of pharmacologically impairing lysosomal Ca^2+^ signaling ([@bib18], [@bib42]; [Figure 8](#fig8){ref-type="fig"}B). We started by specifically inhibiting lysosomal Ca^2+^ storage, which requires a proton gradient to be established by V-ATPases ([@bib40]). To disrupt this gradient, we bath-applied the membrane-permeable Na^+^/H^+^ ionophore monensin (20 μM, 5--10 min). Monensin reduced the bpAP-evoked Ca^2+^ transient (in %ΔF/F; ACSF, 179 ± 24; monensin, 100 ± 14; n = 6 cells; Mann-Whitney test, p \< 0.05; [Figure 2](#fig2){ref-type="fig"}A) despite having no effect on action potential waveform ([Figure S1](#mmc1){ref-type="supplementary-material"}). However, as previously reported, application of monensin resulted in membrane hyperpolarization ([Figure S1](#mmc1){ref-type="supplementary-material"}), likely related to a modest alkalization of intracellular pH ([Figure S2](#mmc1){ref-type="supplementary-material"}; [@bib17]). Therefore, we conducted additional experiments in which lysosomal Ca^2+^ storage was disrupted using the V-ATPase inhibitor bafilomycin. Given the poor membrane permeability of the drug, we pre-incubated slices with bafilomycin (4 μM, 1--2 hr). This had no effect on the action potential waveform or on the resting membrane potential ([Figure S1](#mmc1){ref-type="supplementary-material"}) but caused a significant decrease in the bpAP-associated Ca^2+^ signal that was comparable in magnitude to the decrease obtained in monensin (n = 6 cells/condition; bafilomycin versus control; post hoc Dunn's test, p \< 0.05; [Figure 2](#fig2){ref-type="fig"}B). Notably, subsequent addition of GPN resulted in no further reduction in the Ca^2+^ signal (n = 6 cells; bafilomycin versus GPN, post hoc Dunn's test, p = 0.99; [Figure 2](#fig2){ref-type="fig"}B), suggesting that the effects of bafilomycin were due to its inhibition of the proton gradient in lysosomes as opposed to other organelles.

We next inhibited lysosomal Ca^2+^ release. Lysosomal Ca^2+^ release requires NAADP, which most likely acts on TPCs ([@bib43]). Although low concentrations of NAADP (10--100 nM) evoke Ca^2+^ efflux from the lysosome, higher concentrations (\>100 μM) inhibit it via desensitization of the Ca^2+^ release machinery ([@bib3], [@bib35]). Consistent with this, we found that a concentration of 1 mM NAADP in the patch electrode could inhibit lysosomal Ca^2+^ release in hippocampal neurons ([Figure S3](#mmc1){ref-type="supplementary-material"}). We also found that this concentration of NAADP reduced the bpAP-evoked Ca^2+^ signal (in %ΔF/F; ACSF, 158 ± 10; NAADP desensitization, 110 ± 11; n = 5 cells; post hoc Dunn's test, p \< 0.05; [Figure 2](#fig2){ref-type="fig"}C) and occluded the effects of GPN (n = 5 cells; NAADP versus GPN, post hoc Dunn's test, p = 0.94; [Figure 2](#fig2){ref-type="fig"}C). Similar reductions in Ca^2+^ influx were also observed with the cell-permeable NAADP antagonist NED-19 (100 μM, 30-to 60-min pre-incubation; n = 10 cells; Mann-Whitney test, p \< 0.01; [Figure 2](#fig2){ref-type="fig"}D). NED-19 also decreased the bpAP-associated Ca^2+^ signal in acute hippocampal slices (n = 6 cells; post hoc Dunn's test, p \< 0.05; [Figure 2](#fig2){ref-type="fig"}E), and, again, such reductions occluded the effects of GPN (n = 6 cells; NED-19 versus GPN, post hoc Dunn's test, p = 0.48; [Figure 2](#fig2){ref-type="fig"}E).

Notably, drug-induced decreases in bpAP-evoked Ca^2+^ release did not result from direct inhibition of VGCC currents ([Figure S4](#mmc1){ref-type="supplementary-material"}) or by affecting Ca^2+^ handling ([Figure S5](#mmc1){ref-type="supplementary-material"}) but were likely due to inhibition of lysosomal Ca^2+^ signaling itself.

Ca^2+^ Influx through VGCCs Triggers Lysosomal Ca^2+^ Release {#sec2.3}
-------------------------------------------------------------

Although NAADP is a necessary trigger for lysosomal Ca^2+^ release, it alone does not explain how an electrical signal, such as a bpAP, triggers Ca^2+^ release from the lysosome. We hypothesized that an additional voltage-sensitive mechanism that gates or modulates lysosomal Ca^2+^ release must be present. One possibility is that the lysosomal Ca^2+^ release machinery may be directly voltage-sensitive ([@bib58], [@bib10], [@bib54]). Alternatively, lysosomes may sense voltage indirectly via functional coupling with plasma membrane voltage-gated channels. This coupling may be direct, as in the case of the mechanical coupling between ryanodine receptors and VGCCs in striated muscle ([@bib59]). This coupling may also be indirect and mediated by a second messenger such as Ca^2+^. Indeed, it is known that Ca^2+^ can trigger NAADP-dependent lysosomal Ca^2+^ release ([@bib50], [@bib41]), potentially by directly activating TPCs ([@bib53]. [@bib54]). Thus, it is possible that Ca^2+^ influx from VGCCs during bpAPs may trigger Ca^2+^ release from lysosomes.

To distinguish between these possibilities, we first attempted to image lysosomal Ca^2+^ release in the presence of Ni^2+^ (100 μM) and Cd^2+^ (100 μM) to inhibit VGCCs. This would determine whether the lysosomes could release Ca^2+^ independent of VGCC activity. Under these conditions, we could not detect any Ca^2+^ transients, either in response to a single bpAP (n = 6 cells; post hoc Dunn's test, p = 0.99; [Figures 3](#fig3){ref-type="fig"}A and 3B) or to a more potent, 200-ms step depolarization to \>20 mV (n = 6 cells; post hoc Dunn's test, p = 0.99; [Figures 3](#fig3){ref-type="fig"}A and 3B) compared with unstimulated controls (n = 6). These findings suggest that membrane voltage alone cannot elicit lysosomal Ca^2+^ release and that lysosomal Ca^2+^ signaling requires VGCC activation. To examine specifically whether it was the direct mechanical opening of VGCCs or VGCC-mediated Ca^2+^ influx that was triggering lysosomal Ca^2+^ release, we repeated our experiments in 0 Ca^2+^ ACSF, which prevents VGCC-mediated Ca^2+^ influx but, unlike bath application of Ni^2+^ and Cd^2+^, does so without potential interference of the mechanical opening and closing of VGCCs. Again, under these conditions, we were unable to detect any bpAP-evoked dendritic Ca^2+^ transients, either in response to a single bpAP (n = 5 cells; post hoc Dunn's test, p = 0.99; [Figure 3](#fig3){ref-type="fig"}B) or to a step depolarization to \>20 mV (n = 5 cells; post hoc Dunn's test, p = 0.99; [Figure 3](#fig3){ref-type="fig"}B) compared with unstimulated controls (n = 6). As a positive control, to ensure that our experimental setup was sensitive enough to detect lysosomal Ca^2+^ transients if present, we included low, physiologically relevant concentrations of NAADP (10--100 nM) in our recording electrode to directly trigger Ca^2+^ release from the lysosomes ([@bib9]; [Figure S3](#mmc1){ref-type="supplementary-material"}). Under these conditions, we could reliably detect small and rapid Ca^2+^ transients throughout the dendritic arbor that could be abolished by the NAADP antagonist NED-19. Collectively, our findings suggest that Ca^2+^ influx through VGCCs triggers lysosomal Ca^2+^ release. In this way, lysosomal Ca^2+^ stores are indirectly coupled to VGCCs, enabling them to be mobilized by changes in membrane voltage that occur during bpAPs.

In many cell types, lysosomal Ca^2+^ release is functionally coupled to Ca^2+^ release from the ER as opposed to VGCCs ([@bib50], [@bib19], [@bib39]). Previous studies, however, have demonstrated that the ER does not contribute to bpAP-evoked Ca^2+^ transients ([@bib33], [@bib16], [@bib29]), arguing against lysosome-ER coupling in neuronal dendrites. In line with this, we found that blocking ER Ca^2+^ signaling with either ryanodine (20 μM, 20 min) or thapsigargin (15 μM, 20 min) had no effect on the amplitude of bpAP-evoked Ca^2+^ transients (n = 5 cells/condition; Kruskal-Wallis test, p \> 0.05; [Figures 3](#fig3){ref-type="fig"}C and 3D). In a subset of experiments with thapsigargin, subsequent addition of GPN resulted in the expected reduction of bpAP-evoked Ca^2+^ signaling (n = 3 cells; paired t test, p \< 0.05; [Figures 3](#fig3){ref-type="fig"}C and 3D). Collectively, these findings suggest that the ER is unlikely to play a role in bpAP-evoked lysosomal Ca^2+^ release.

We also examined the possibility that lysosomal Ca^2+^ release was coupled to mitochondrial Ca^2+^ stores. Consistent with a previous report ([@bib33]), application of the mitochondrial uncoupler FCCP (1 μM, 5 min) had no effect on bpAP-evoked Ca^2+^ transients (n = 5 cells; Kruskal-Wallis test, p \> 0.05; [Figure 3](#fig3){ref-type="fig"}D) and failed to occlude the effects of GPN (n = 5 cells; paired t test, p \< 0.05; [Figure 3](#fig3){ref-type="fig"}D). These findings suggest that, under our experimental conditions, the lysosome is the only internal Ca^2+^ store that contributes to bpAP-evoked Ca^2+^ signaling and is functionally coupled to VGCCs.

Lysosomal Ca^2+^ Signaling Drives Fusion of the Lysosomes with the Plasma Membrane {#sec2.4}
----------------------------------------------------------------------------------

What might be the function of lysosomal Ca^2+^ release in neurons? The lysosome itself is known to undergo Ca^2+^-dependent fusion both with other organelles and with the plasma membrane ([@bib32]). The source of Ca^2+^ in such instances can be the lysosome itself ([@bib55], [@bib31], [@bib32], [@bib13], [@bib18]). Lysosomal fusion to the plasma membrane has been shown to release chemical messengers or enzymes in several cell types ([@bib32], [@bib18]). If present in neurons, such a mechanism could have implications for activity-dependent processing in dendrites. Additionally, our finding of the strong functional coupling between VGCC activation and lysosomal Ca^2+^ release in neurons suggests that lysosomes would be ideally situated for activity-dependent fusion with the plasma membrane, akin to synaptic vesicles in the presynaptic terminal.

We investigated whether activity-dependent release of Ca^2+^ from the lysosome could trigger fusion of the lysosome to the plasma membrane in neuronal dendrites. We started by using total internal reflection fluorescence microscopy (TIRFM) to monitor the dynamics of LysoTracker-stained lysosomes near the plasma membrane in dissociated hippocampal cultures. We found weak LysoTracker labeling in the dendrites under baseline conditions ([Figure 4](#fig4){ref-type="fig"}A). However, when we elevated extracellular K^+^ to 45 mM to drive strong dendritic depolarization and VGCC activity ([@bib64], [@bib65]), we observed a marked increase in the intensity of labeled puncta ([Figure 4](#fig4){ref-type="fig"}B) and an overall increase in surface fluorescence (6.50%ΔF/F ± 0.05%ΔF/F; n = 5 cells; z test versus 0, p \< 0.01; [Figure 4](#fig4){ref-type="fig"}A; [Movie S1](#mmc2){ref-type="supplementary-material"}). Depolarization had no such effects on cells pre-incubated with NED-19, and, instead, only decreases in fluorescence were observed because of the effects of photobleaching (−1.62%ΔF/F ± 0.76%ΔF/F; n = 5 cells; NED-19 versus K^+^, Mann-Whitney test, p \< 0.05; [Figures 4](#fig4){ref-type="fig"}A and 4B). These findings suggest that membrane depolarization mobilized lysosomes close to the cell surface and in a manner dependent on lysosomal Ca^2+^ signaling; however, from these data alone, we could not determine whether such mobilization was followed by fusion of the lysosome with the plasma membrane.

We next used live-cell immunolabeling in dissociated neurons to examine whether lysosomes were capable of fusing with the plasma membrane in an activity-dependent manner. We applied a fluorescently labeled antibody targeting the lumenal domain of the lysosome-associated membrane protein LAMP-2 during K^+^-mediated depolarization. Under these conditions, fluorescent labeling of LAMP-2 would require lysosomes to fuse with the plasma membrane ([Figure 4](#fig4){ref-type="fig"}C). Using this technique, we found that membrane depolarization resulted in significantly greater amounts of immunofluorescence in the dendrite compared with control conditions (in arbitrary fluorescence units \[AFU\]; K^+^, 35 ± 4; control, 24 ± 2; n = 23 cells/condition; post hoc Dunn's test, p \< 0.05; [Figure 4](#fig4){ref-type="fig"}D). Knocking out LAMP-2 using CRIPSR/Cas9 abolished all surface labeling, confirming that immunofluorescence was specifically associated with LAMP-2 labeling ([Figure S6](#mmc1){ref-type="supplementary-material"}). Moreover, pre-incubation of cells with either NED-19 or bafilomycin abolished activity-induced increases in LAMP-2 fluorescence (n = 10 cells; NED-19 versus NED-19 + K^+^, post hoc Dunn's test, p = 0.86;; n = 11 cells; bafilomycin versus bafilomycin + K^+^, post hoc Dunn's test, p = 0.93; [Figure 4](#fig4){ref-type="fig"}D). These findings suggest that neuronal depolarization drives lysosomal fusion with the plasma membrane and in a manner dependent on activity-evoked lysosomal Ca^2+^ release.

To image lysosomal fusion with improved rapidity and sensitivity, we made use of superecliptic pHlourin (SEP), a pH-sensitive GFP that is commonly used as a probe for synaptic vesicle fusion. We tagged SEP to the lumenal domain of LAMP-2 ([Figure 5](#fig5){ref-type="fig"}A). The fluorescence of LAMP2-SEP, which would be otherwise quenched in the acidic environment of the lysosome, should be detected upon exposure to the pH neutral environment of the extracellular fluid following lysosomal fusion with the plasma membrane. We expressed LAMP2-SEP in dissociated cultures. LAMP2-SEP localized to lysosomes, retained its pH sensitivity, and exhibited maximal fluorescence upon de-acidification of the lysosome with NH~4~Cl ([Figure S7](#mmc1){ref-type="supplementary-material"}). Moreover, upon K^+^ stimulation, we observed a large and rapid increase in LAMP2-SEP fluorescence throughout the dendritic arbor (68%ΔF/F ± 17%ΔF/F; n = 5 cells; versus baseline; Mann-Whitney test, p \< 0.05; [Figures 5](#fig5){ref-type="fig"}B--5D). This was followed by a return to basal fluorescence within 65 s (n = 5 cells; fluorescence at 65 s versus baseline; Mann-Whitney test, p = 0.85; [Figures 5](#fig5){ref-type="fig"}B and 5C; [Movie S2](#mmc3){ref-type="supplementary-material"}), likely reflecting the surface retrieval and re-acidification of LAMP-2. Fusion of the lysosome with the plasma membrane in several cell types has previously been shown to require the actions of synaptotagmin 7 (Syt7) and can be blocked by loading cells with the cytosolic domain of Syt7 ([@bib34], [@bib32]). Therefore, to confirm that increases in LAMP2-SEP fluorescence reflected bona fide fusion of the lysosome with the plasma membrane, we loaded cells with the cytosolic domain of recombinant Syt7 (100 μg/mL). Under these conditions, we detected no increases in fluorescence following K^+^ treatment (n = 5 cells; Syt7 versus control, post hoc Dunn's test, p \< 0.05; [Figures 5](#fig5){ref-type="fig"}C and 5D). Increases in fluorescence were also abolished by NED-19 (n = 7 cells; versus control, post hoc Dunn's test, p \< 0.05; [Figures 5](#fig5){ref-type="fig"}C and 5D), even when Ca^2+^ influx from VGCCs was increased by elevating extracellular Ca^2+^ from 2 mM to 4 mM and by adding the voltage-gated K^+^ channel blocker 4-AP (100 μM) (n = 7 cells; NED-19 with high Ca^2+^ versus control, post hoc Dunn's test, p \< 0.05; [Figures 5](#fig5){ref-type="fig"}C and 5D). These findings confirm that LAMP2-SEP can detect fusion of lysosomes with the plasma membrane and that Ca^2+^ release from lysosomal stores is integral for the fusion of the lysosome with the plasma membrane even when Ca^2+^ influx from VGCCs is augmented.

LAMP2-SEP gave us the added advantage of examining whether lysosome fusion could be triggered by dendritic depolarization evoked by bpAPs. Because we could not reliably detect increases in LAMP2-SEP fluorescence to a single bpAP, we made use of the alkaline trap method ([@bib21]), which blocks vesicle re-acidification with the V-ATPase inhibitor bafilomycin. This would enable fusion-mediated increases in LAMP2-SEP fluorescence, if present, to accumulate to measurable levels during repeated stimulation despite LAMP-2 surface retrieval ([Figure 5](#fig5){ref-type="fig"}E). It is important to mention that, although chronic incubation (\>60 min) of bafilomycin inhibited lysosomal Ca^2+^ signaling ([Figure 2](#fig2){ref-type="fig"}B), acute applications had no effect, likely because of the poor membrane permeability of the drug. In keeping with this, brief application of bafilomycin (\<10 min) in the absence of any electrical stimulation produced no change in LAMP2-SEP fluorescence (n = 6 cells; z test versus 0, p = 0.93; [Figure 5](#fig5){ref-type="fig"}G), suggesting that the drug alone had no effect on lysosomal pH. However, we did observe robust increases in fluorescence when bafilomycin application was followed by low-frequency (5-Hz) stimulation of 300 bpAPs, which was achieved using field electrodes (27%ΔF/F ± 6%ΔF/F; n = 6 cells; versus no stimulation; post hoc Dunn's test, p \< 0.01; [Figures 5](#fig5){ref-type="fig"}F and 5G). No such increases were observed when stimulation was delivered in the presence of NED-19 (n = 7 cells; versus no stimulation; post hoc Dunn's test, p = 0.99; [Figure 5](#fig5){ref-type="fig"}G) or following intracellular loading of Syt7 (n = 5 cells; versus no stimulation; post hoc Dunn's test, p = 0.44; [Figure 5](#fig5){ref-type="fig"}G). Our findings suggest that bpAP-evoked lysosomal Ca^2+^ release triggers lysosomal fusion with the plasma membrane.

Lysosomal Fusion Results in the Release of Cathepsin B {#sec2.5}
------------------------------------------------------

The fusion of the lysosome with the plasma membrane likely results in the release of its contents into the extracellular space. We hypothesized that the release of lysosomal proteases may be required for the activity-dependent restructuring of the extracellular matrix (ECM). This would be of potential relevance for long-term synaptic changes, which are known to require ECM remodelling ([@bib63], [@bib14]). In this regard, Cathepsin B was of particular interest to us. The cathepsins are a family of lysosomal proteases that generally show preferential activation in acidic environments. Cathepsin B, however, exhibits enzymatic activity in both acidic and pH-neutral environments, suggesting that, upon lysosomal fusion, Cathepsin B would likely retain some form of enzymatic activity in the pH-neutral extracellular space ([@bib44], [@bib30]).

We first examined whether Cathepsin B could, in fact, be released by neuronal lysosomes in an activity-dependent manner. We incubated dissociated hippocampal neurons with Magic Red Cathepsin B fluorogenic substrate, which fluoresces upon Cathepsin B-mediated cleavage. Application of the substrate resulted in labeling of fluorescent puncta that co-localized with LysoTracker, confirming that active Cathepsin B was ubiquitously present in neuronal lysosomes ([Figure 6](#fig6){ref-type="fig"}A; [Figure S8](#mmc1){ref-type="supplementary-material"}). Magic Red fluorescence also co-localized with Cathepsin B-GFP fluorescence, confirming that it was labeling Cathepsin-B containing compartments ([Figure S8](#mmc1){ref-type="supplementary-material"}). We then stimulated cultures with 45 mM K^+^ and found that this resulted in a loss of Magic Red fluorescence in some of the imaged puncta, consistent with the notion of lysosomal exocytosis, and the loss of Cathepsin B activity from these sites ([Figure 6](#fig6){ref-type="fig"}A). A similar loss of fluorescence was seen with LysoTracker ([Figure 6](#fig6){ref-type="fig"}A; [Figure S8](#mmc1){ref-type="supplementary-material"}). The average loss of Magic Red fluorescence across puncta (−15.6%ΔF/F ± 1.6%ΔF/F; n = 226 puncta from 6 cells; [Figure 6](#fig6){ref-type="fig"}B) was significantly greater than in unstimulated cultures (n = 254 puncta from 5 cells; post hoc Dunn's test, p \< 0.01; [Figure 6](#fig6){ref-type="fig"}B), and in cultures pre-treated with NED-19 (n = 152 puncta from 5 cells; post hoc Dunn's test, p \< 0.01; [Figure 6](#fig6){ref-type="fig"}B). We defined puncta undergoing fusion as those exhibiting a loss of Magic Red fluorescence of \>3 SD from the average fluorescent change measured in unstimulated control experiments. Using this metric, we found that, with K^+^ stimulation, the fraction of Cathepsin B puncta undergoing fusion (8.4% ± 1.8%; n = 226 puncta from 6 cells; [Figure 6](#fig6){ref-type="fig"}C) was significantly greater than that found in unstimulated controls (n = 254 puncta from 5 cells; corrected z test, p \< 0.01; [Figure 6](#fig6){ref-type="fig"}C) or in cultures pre-treated with NED-19 (n = 152 puncta from 5 cells; versus K^+^ stimulation; corrected z test, p \< 0.01; [Figure 6](#fig6){ref-type="fig"}C). Live-cell immunolabeling of synapses with anti-GluA1 antibodies additionally revealed that \>95% of Cathepsin B puncta, both the total pool of puncta and those undergoing activity-dependent fusion, were located within 1 μm of a GluA1-labeled punctum ([Figure S8](#mmc1){ref-type="supplementary-material"}), suggesting that Cathepsin B release occurs in the vicinity of synapses.

Cathepsin B Release Activates MMP-9 {#sec2.6}
-----------------------------------

ECM remodelling is canonically associated with matrix metalloproteinases (MMPs). One means by which Cathepsin B can promote ECM remodelling is by recruiting MMP activity. It does so by cleaving TIMP-1, an endogenous and potent inhibitor of MMP signaling ([@bib28], [@bib45]). We therefore examined whether activity-dependent release of lysosomal Cathepsin B could contribute to ECM remodeling in cultured hippocampal slices. Using an ELISA, we first confirmed whether we could detect activity-dependent elevations of Cathepsin B in the extracellular fluid. Similar to our findings in dissociated neurons, we found that K^+^ treatment elevated extracellular Cathepsin B in hippocampal slices (in a.u.; control,0.19 ± 0.011; n = 8 slices; K^+^, 0.31 ± 0.006; n = 5 slices; post hoc Bonferroni test, p \< 0.01; [Figure 6](#fig6){ref-type="fig"}D). Pre-treatment with NED-19 greatly reduced this activity-dependent increase (n = 7 slices; NED-19 + K^+^ versus K^+^; post hoc Bonferroni test, p \< 0.01; [Figure 6](#fig6){ref-type="fig"}D), although it did not quite abolish it (n = 7 and 5 slices; NED-19 versus NED-19 + K^+^; post hoc Bonferroni test, p \< 0.05, [Figure 6](#fig6){ref-type="fig"}D). We next examined whether extracellular Cathepsin B was enzymatically active. To do so, we incubated slices with a Cathepsin B fluorogenic substrate (Z-Arg-Arg-AMC) and monitored increases in extracellular fluorescence as a readout of enzymatic activity ([Figure 6](#fig6){ref-type="fig"}E). Cathepsin B activity was minimal under control conditions (77 ± 502 AFU; n = 5 slices; z test versus 0, p = 0.87; [Figure 6](#fig6){ref-type="fig"}E), greatly enhanced after K^+^ stimulation (1,717 ± 850 AFU; n = 5 slices; K^+^ versus control; post hoc Bonferroni test, p \< 0.05; [Figure 6](#fig6){ref-type="fig"}E), and abolished by NED-19 (n = 5 slices/condition; NED-19 versus NED-19 + K^+^; post hoc Bonferroni test, p = 0.99; [Figure 6](#fig6){ref-type="fig"}E). Collectively, these findings are consistent with the activity-dependent release of active Cathepsin B from lysosomal stores.

Cathepsin B is able to activate MMP signaling by cleaving the MMP inhibitor TIMP-1 ([@bib28], [@bib45]). We therefore examined whether activity-dependent release of lysosomal Cathepsin B could mediate an increase in extracellular MMP activity in hippocampal tissue. To examine this, we incubated hippocampal slices with a broadly selective MMP fluorogenic substrate (PEPDAB0502), which fluoresces upon MMP-mediated cleavage ([@bib37]). We examined MMP-associated fluorescence either in the presence or absence of the membrane-impermeable Cathepsin B inhibitor CA-074 (1 μM), which we used to selectively inhibit extracellular Cathepsin B activity ([@bib30], [@bib38]). Notably, we saw no effect of CA-074 on MMP activity under basal conditions (in AFU; control, 2,083 ± 207; n = 29 slices; CA-074, 1,601 ± 317; n = 15 slices; post hoc Bonferroni test, p = 0.40; [Figure 6](#fig6){ref-type="fig"}F). However, given our finding that Cathepsin B release is activity-dependent, we repeated the experiment under high K^+^ conditions to promote Cathepsin B secretion from lysosomal stores. Under these conditions we found that MMP activity was significantly greater than that of controls (AFU = 4,725 ± 259; n = 13 slices; K^+^ versus control; post hoc Bonferroni test, p \< 0.01; [Figure 6](#fig6){ref-type="fig"}F) and now sensitive to Cathepsin B inhibition by CA-074 (AFU = 3,187 ± 317; n = 12 slices; CA-074 versus K^+^; post hoc Bonferroni test, p \< 0.01; [Figure 6](#fig6){ref-type="fig"}F). These findings are consistent with the idea that activity-dependent release of Cathepsin B stimulates MMP activity in hippocampal slices.

Several studies have demonstrated that MMP-9, in particular, is necessary for the maintenance of long-term potentiation (LTP) and dendritic spine growth ([@bib62], [@bib63], [@bib14]). We were therefore interested in examining how Cathepsin B affected MMP-9 activity in hippocampal slices. For this purpose, we again incubated slices with the MMP fluorogenic substrate but did so either in the presence or absence of an MMP-9 inhibitor (100 nM MMP-9 inhibitor I). We took the reduction in MMP-associated fluorescence that occurred in the presence of the inhibitor as a readout of the levels of MMP-9 activity present under a particular condition. Under control conditions, we detected a small but significant level of MMP-9 activity (AFU = 635 ± 220; n = 14 slices; z test, p \< 0.01; [Figure 6](#fig6){ref-type="fig"}G). Given that MMP-9 activation is driven by neuronal activity and not normally detectable under baseline conditions ([@bib46], [@bib15]), we reasoned that the MMP-9 activity in our experiment was likely driven by spontaneous neuronal activity in our slices. Indeed, we found that MMP-9 activity was abolished in the presence of TTX (n = 9 slices; z test versus 0, p \> 0.05; [Figure 6](#fig6){ref-type="fig"}G), although this did not reach significance compared with control levels of activity (post hoc Bonferroni test, p = 0.21). Conversely, elevating neuronal activity by K^+^ stimulation greatly enhanced MMP-9 activity from control levels (AFU = 2,592 ± 439; n = 10 slices; K^+^ versus control; post hoc Bonferroni test, p \< 0.01; [Figure 6](#fig6){ref-type="fig"}G). Given that K^+^ stimulation also enhances Cathepsin B release, we asked whether activity-dependent release of Cathepsin B was necessary for the activity-dependent increase in MMP-9 activity. We found that addition of either CA-074, to inhibit extracellular Cathepsin B, or NED-19, to prevent activity-dependent Cathepsin B release, abolished MMP-9 activity in K^+^ stimulated slices (CA-074, n = 11 slices; versus K^+^; post hoc Bonferroni test, p \< 0.01; NED-19, n = 5 slices; post hoc Bonferroni test, versus K^+^, p \< 0.01; [Figure 6](#fig6){ref-type="fig"}G). Therefore, activity-dependent increase of MMP-9 activity in hippocampal slices requires activity-dependent release of Cathepsin B.

MMP-9 and its endogenous inhibitor TIMP-1 co-localize to secretory vesicles and are co-released with neuronal activity ([@bib46], [@bib60], [@bib15]). MMP-9 activity, therefore, will not necessarily depend on the absolute levels of MMP-9 in tissue but on the ratio of MMP-9 to TIMP-1. Therefore, to provide additional evidence that Cathepsin B is capable of recruiting MMP-9 activity, we examined the MMP-9/TIMP-1 ratio in hippocampal slices. We reasoned that this ratio should be increased by neuronal activity and in a manner dependent on lysosomal Cathepsin B. In agreement with this, western blot analysis showed a marked increase in the MMP-9/TIMP-1 ratio in slices treated with K^+^ ([Figure S9](#mmc1){ref-type="supplementary-material"}). Inhibiting Cathepsin B release with NED-19 or Cathepsin B activity with CA-074 inhibited these increases ([Figure S9](#mmc1){ref-type="supplementary-material"}).

Cathepsin B Release Is Necessary for MMP-9-Mediated Long-Lasting Structural Plasticity {#sec2.7}
--------------------------------------------------------------------------------------

Long-lasting changes in synaptic function are thought to ultimately require stable, structural changes in the pre- or post-synaptic elements, with LTP induction being associated with long-lasting expansion of the postsynaptic density and a stable enlargement of the dendritic spine head. Such changes require ECM remodelling by MMP-9 ([@bib62], [@bib63], [@bib14]). Given that lysosomal-mediated release of Cathepsin B provides a means by which neuronal activity can trigger activation of MMP-9, we hypothesized that the lysosome would play a pivotal role in the maintenance of structural plasticity. We therefore examined the effect that inhibiting lysosomal Ca^2+^ signaling and fusion with NED-19 would have on structural enlargements of dendritic spines induced by Hebbian pairing. For this purpose, we filled CA1 neurons with Alexa Fluor 488 dye to visualize spine structure and induced LTP by pairing brief (1 ms) photolysis of caged glutamate on a target spine with 3--5 bpAPs ([Figure 7](#fig7){ref-type="fig"}A). The pairing was repeated 60 times at 5 Hz. This protocol produced a rapid and long-lasting expansion of the target spine that was present at 1 min following stimulation (foldΔ = 1.75 ± 0.12; n = 9 cells; z test versus 1.00, p \< 0.01; [Figures 7](#fig7){ref-type="fig"}B and 7E) and remained stable for at least 60 min thereafter (n = 9 cells; foldΔ at 60 min versus 1 min; Mann-Whitney, p = 0.61; [Figure 7](#fig7){ref-type="fig"}B). No enlargements were observed at neighboring spines (n = 9 cells; z test versus 1.00, p = 0.37; [Figures 7](#fig7){ref-type="fig"}B and 7E). Remarkably, NED-19 abolished long-lasting changes in structural growth (n = 6 cells; foldΔ at 60 min; z test versus 1.00, p = 0.78; [Figures 7](#fig7){ref-type="fig"}B and 7E) despite having no effect on the initial spine growth recorded 1 min after paired stimulation (n = 6 cells; versus control; Kruskal-Wallis, p = 0.29; [Figures 7](#fig7){ref-type="fig"}B and 7E); similar results were obtained when lysosomal Ca^2+^ release was instead inhibited with desensitizing concentrations of NAADP in the recording electrode (n = 6 cells; foldΔ at 1 min versus control; Kruskal-Wallis, p = 0.29; foldΔ at 60 min, z test versus 1.00, p = 0.46; [Figures 7](#fig7){ref-type="fig"}B and 7E) or when lysosomal fusion was inhibited with intracellular loading of the cytosolic domain of Syt7 (n = 5 cells; foldΔ at 1 min versus control; Kruskal-Wallis, p = 0.29; foldΔ at 60 min; z test versus 1.00, p = 0.46; [Figures 7](#fig7){ref-type="fig"}B and 7E). These findings suggest that lysosomal Ca^2+^ release and fusion are specifically involved in the maintenance, as opposed to the induction, of structural plasticity; a very similar role has been reported for MMP-9 ([@bib62]). We hypothesized that the reason why pharmacological impairment of lysosomal function prevented structural plasticity was a failure of the postsynaptic neuron to release Cathepsin B during neuronal activity. Consistent with this idea, we found that inhibition of extracellular Cathepsin B with CA-074, was able to phenocopy the effects of NED-19 (n = 5 cells; foldΔ at 1 min; CA-074 versus NED-19; post hoc Dunn's test, p = 0.66; foldΔ at 60 min; CA-074 versus NED-19; post hoc Dunn's test, p = 0.99; [Figures 7](#fig7){ref-type="fig"}C and 7E), whereas exogenous application of active Cathepsin B (5 μg/mL applied for 10 min after the start of pairing) rescued the NED-19 phenotype, restoring persistent expansion of the target spine to control levels (foldΔ at 60 min = 1.87 ± 0.14; n = 5 cells; versus control; post hoc Dunn's test, p = 0.99; [Figures 7](#fig7){ref-type="fig"}C and 7E) without affecting neighboring spines (n = 5 cells; Kruskal-Wallis test, p = 0.72; [Figures 7](#fig7){ref-type="fig"}C and 7E). In contrast, addition of active Cathepsin B in control experiments did not further augment spine expansion (n = 5 cells; versus control; post hoc Dunn's test, p = 0.99; [Figures 7](#fig7){ref-type="fig"}C and 7E), suggesting that Cathepsin B activity was not a limiting factor under normal conditions of plasticity induction. To then test whether the function of lysosome fusion and Cathepsin B release, in the context of structural plasticity, was to ultimately activate MMP-9, we attempted to rescue the plasticity deficits induced by CA-074 and NED-19 by exogenous application of active MMP-9 (5 μg/mL applied for 10 min after the start of pairing). We found that MMP-9 did indeed restore persistent expansion of the target spine to control levels in both NED-19- and CA-074-treated slices (NED-19 + MMP-9, n = 5 cells; foldΔ at 60 min versus control; post hoc Dunn's test, p = 0.99; CA-074 + MMP-9, n = 5 cells; foldΔ at 60 min; versus control; post hoc Dunn's test, p = 0.99; [Figures 7](#fig7){ref-type="fig"}D and 7E) without affecting neighboring spines (NED-19 + MMP-9, n = 5 cells; Kruskal-Wallis test, p = 0.72; CA-074 + MMP-9, n = 5 cells; Kruskal-Wallis test, p = 0.72; [Figures 7](#fig7){ref-type="fig"}D and 7E). Notably, addition of active MMP-9 in control experiments did not further augment spine expansion (n = 5 cells; foldΔ at 60 min versus control; post hoc Dunn's test, p = 0.99; [Figures 7](#fig7){ref-type="fig"}D and 7E), suggesting that the activity of MMP-9, like that of Cathepsin B, was not a limiting factor under normal conditions of plasticity induction.

Discussion {#sec3}
==========

Here we found that dendritic Ca^2+^ influx from VGCCs during bpAPs triggered Ca^2+^ release from the lysosome. This Ca^2+^ release led to the fusion of the lysosome with the plasma membrane, resulting in the release of Cathepsin B and the subsequent recruitment of MMP-9 activity. We found that activity-dependent enhancement of MMP-9 signaling by Cathepsin B was necessary for the maintenance of the long-lasting dendritic spine growth that accompanies Hebbian pairing of synaptic activity with postsynaptic bpAPs ([Figure 8](#fig8){ref-type="fig"}A).

Our finding that bpAPs can trigger Ca^2+^ release from the lysosome is unexpected because it has long been thought that bpAP-evoked Ca^2+^ influx is mediated exclusively by VGCCs with little or no contribution from intracellular stores. The evidence for this comes from the fact that bpAP-evoked Ca^2+^ signals are essentially abolished following VGCC inhibition or removal of extracellular Ca^2+^ ([@bib26], [@bib12], [@bib61], [@bib23]), whereas inhibition of ER or mitochondrial Ca^2+^ signaling is without effect ([@bib33], [@bib16], [@bib29]). We found similar effects in our own study when blocking VGCC-, ER-, and mitochondrion-mediated Ca^2+^ signaling; however, we were also able to unmask a role for lysosomal stores. Notably, we found no evidence of lysosomal Ca^2+^ release under conditions in which VGCC-mediated Ca^2+^ influx was inhibited, suggesting that lysosomal Ca^2+^ release was likely triggered by Ca^2+^ influx through VGCCs. Others have demonstrated that Ca^2+^ from other sources, such as the ER, can trigger lysosomal Ca^2+^ release ([@bib50], [@bib41]), potentially by directly activating TPCs ([@bib53], [@bib54]); although the exact mechanism remains unclear, it does suggest that TPCs are regulated both by Ca^2+^ and by NAADP. To the best of our knowledge, we are the first to report evidence of a functional coupling between VGCCs and lysosomes, which may potentially be a feature unique to excitable tissue. Certainly, such a coupling is an efficient means of endowing lysosomes with voltage sensitivity, thereby enabling lysosomal Ca^2+^ release to be driven by neuronal activity.

Although Ca^2+^ release from the lysosomes may serve a number of functions, in this study, we found that it drove the fusion of lysosomes with the plasma membrane. Why Ca^2+^ release from the lysosome, as opposed to other sources, is particularly important for its fusion with the plasma membrane is not clear, but a similar mechanism is thought to underlie lysosomal exocytosis in other cell types ([@bib13], [@bib18]) and suggests that the lysosomal fusion machinery is sensitive to nanodomain Ca^2+^ signaling generated locally by the organelle itself. It is, however, important to note that, from out data alone, we cannot determine whether the lysosomes releasing Ca^2+^ in response to bpAPs are those that subsequently undergo fusion with the plasma membrane; it is possible that distinct subpopulations of lysosomes may differentially mediate these functions.

We found that fusion of the lysosome was accompanied by the release of Cathepsin B into the extracellular space. Cathepsin B release has generally been reported in the context of pathological conditions. In neural tissue, excessive levels of extracellular Cathepsin B release have been associated with cell death in traumatic brain injury, brain aneurysm, and several neurologic diseases such as aminotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and Huntington's disease ([@bib52], [@bib24]). Potential mediators of Cathepsin B release under these conditions include reactive astrocytes, microglia, and/or macrophages ([@bib57], [@bib30], [@bib27], [@bib20], [@bib45]). Although the exact mechanism by which these cells release Cathepsin B is not clear, if it involves lysosomal fusion with the plasma membrane, as reported in this study, then pharmacological inhibition of lysosomal Ca^2+^ signaling may provide a novel means for preventing excessive Cathepsin B release under pathological conditions.

We showed that Cathepsin B release was essential for the maintenance of long-term structural plasticity, likely by recruiting MMP-9 activity via cleavage of TIMP-1 ([@bib28], [@bib45]). Although several studies have demonstrated a role for MMP-9 in long-term synaptic plasticity, the mechanism by which neuronal activity triggers an increase in MMP-9 activity is not completely understood ([@bib63], [@bib14]). In the context of LTP, it is known that neuronal stimulation triggers the transport and translation of MMP-9 mRNA in neuronal dendrites, followed by MMP-9 release into the ECM ([@bib46], [@bib15]), where it is converted into its active form, likely via plasmin-mediated cleavage of the MMP-9 pro-domain ([@bib63]). However, upon secretion, MMP-9 is complexed with its inhibitor TIMP-1 ([@bib60]), which is capable of inhibiting both active and inactive forms of MMP-9 ([@bib47]). Inhibition of TIMP-1 signaling, therefore, is likely to be crucial for the maintenance of LTP. Based on our results, we would suggest that the activity-dependent secretion of Cathepsin B from neuronal lysosomes is one possible means by which TIMP-1 signaling can be inhibited ([Figure 8](#fig8){ref-type="fig"}).

Although traditionally viewed as the degradative compartment of the cell, a growing body of evidence suggests that the lysosome functions as a Ca^2+^ store that is capable of mediating a diverse array of physiological functions across numerous cell types ([@bib19], [@bib18]). In this study, we examined the role of lysosomes in neurons. Our findings reveal that lysosomes mediate activity-dependent Ca^2+^ signaling in the dendrites and, via the release of Cathepsin B, play an important and unexpected role in the long-term maintenance of structural plasticity.

Experimental Procedures {#sec4}
=======================

Hippocampal Tissue Preparation {#sec4.1}
------------------------------

All animal work was carried out in accordance with the Animals (Scientific Procedures) Act, 1986 (UK) and under project and personal licenses approved by the Home Office (UK). Acute coronal hippocampal slices (350--400 μm) were prepared from male Wistar rats (post-natal day 14 \[P14\]--P21) and perfused (3 mL/min) with ACSF (120 mM NaCl, 2.5 mM KCl, 2 mM CaCl~2~, 1 mM MgCl~2~, 1.2 mM NaH~2~PO~4~, 26 mM NaHCO~3~, 11 mM glucose, 0.2 mM ascorbic acid, and 1 mM Trolox; pH = 7.2--7.4; 32°C--34°C; 95% O~2~ and 5% CO~2~). Cultured hippocampal slices (350 μm) were prepared from male Wistar rats (P7). Slices (days in vitro \[DIV\] 10--15) were perfused (1--2 mL/min) with heated ACSF (32°C--34°C). For dissociated cultures, hippocampal cells from P1 male Wistar rats were plated onto 18-mm coverslips (3--6 × 10^4^ cells/coverslip), pre-coated with poly-D-lysine (0.1 mg/mL) and fibronectin (0.05 mg/mL), and imaged on DIV 10--21 in Tyrode's buffer (128 mM NaCl, 5 mM KCl, 1 mM MgCl~2~, 2 mM CaCl~2~, 4.2 mM NaHCO~3~, 20 mM glucose, and 15 mM HEPES; pH = 7.2--7.4; 22°C--24°C). For K^+^ stimulation, 30 or 45 mM NaCl was replaced with KCl. See [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for further details.

Ca^2+^ Imaging and Electrophysiology {#sec4.2}
------------------------------------

CA3 or CA1 cells in hippocampal slices were recorded using either sharp microelectrodes (70--120 MΩ) or high-resistance patch electrodes (16--25 MΩ) to minimize intracellular dialysis. For Ca^2+^ imaging, sharp microelectrodes contained 0.5--1 mM OGB-1 (Thermo Fisher Scientific) dissolved in 200--400 mM potassium acetate. Patch electrodes contained OGB-1 (0.1--0.2 mM) dissolved in internal solution (135 mM KGluconate, 10 mM KCl, 10 mM HEPES, 2 mM MgCl~2~, 2 mM Na~2~ATP, and 0.4 mM Na~3~GTP; pH = 7.2--7.4). Apical dendrites were imaged using confocal laser-scanning microscopy and a 488-nm argon laser. bpAPs were triggered with somatic current injection (1--2 nA, 5--10 ms) and recorded with an AxocLAMP-2B amplifier (Axon Instruments). See [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for further details.

Cathepsin B and MMP Assays {#sec4.3}
--------------------------

Assays were done on slice culture supernatant using a plate reader. Cathepsin B levels were assessed using a colorimetric human Cathepsin B ELISA kit (ab119684, Abcam)according to the manufacturer's instructions. Cathepsin B and MMP activity was assessed by incubating slices either with the Cathepsin B fluorogenic substrate Z-Arg-Arg-AMC (1:200, JA7740, Merck Millipore) or a MMP fluorogenic substrate (5 μM PEPDAB0502, Biozyme) for 2 hr and examining fluorescence in the supernatant. MMP-9 activity levels were calculated as the difference in MMP fluorescence obtained in the absence and presence of an MMP-9 inhibitor (100 nM of MMP-9 inhibitor I). See [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for further details.

Structural Plasticity and Spine Imaging {#sec4.4}
---------------------------------------

CA1 cells in slice cultures were patched (16--25 MΩ) with KGluconate internal solution containing Alexa Fluor 488 (0.1--0.2 mM, Thermo Fisher Scientific). Small dendritic spines (\<1 μm) were targeted for MNI-glutamate spot photolysis using a 405-nm laser (Photonics). LTP was induced by pairing photolysis (1 ms) with three to five action potentials. Pairing was repeated 60 times at 5 Hz. Fractional changes in fluorescence of the spine head, standardized to that of the underlying dendrite, were used to estimate fractional changes in spine volume. See [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for further details.

Statistical Analysis {#sec4.5}
--------------------

Significance was assessed using parametric tests (two-tailed paired and unpaired t test) or non-parametric tests (two-tailed Mann-Whitney test or two-tailed Wilcoxon matched-pairs test) in which a normal distribution of data could not be confirmed. One-sample z tests were used for comparisons against a known value. The Pearson correlation coefficient was used for assessing the significance of linear trends. For multiple comparisons, ANOVA and post hoc Bonferroni's tests (parametric) or the Kruskal-Wallis test with post hoc Dunn's tests (non-parametric) were used. In the text, values are quoted as mean ± SEM, and significance is quoted either at the p \< 0.05 or p \< 0.01 level.
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Document S1. Supplemental Experimental Procedures and Figures S1--S9Movie S1. Imaging Activity-Dependent Mobilization of Lysosomes at the Cell Surface, Related to Figure 4Sample video clip of TIRF imaging experiments of lysosomes shown in Figure 4A. Two dissociated hippocampal neurons (soma are on the bottom right) were loaded with LysoTracker (green fluorescence) to label lysosomes. The experiment starts with a baseline recording. After which, the culture is stimulated with 45 mM K^+^; this period is denoted with a label reading "K^+^" on the top left corner of the video. During stimulation, there is a rapid emergence of fluorescence puncta throughout the dendritic arbour, which are not seen during baseline imaging. Frames were acquired at the rate of 1/s and are played at a rate of 4/s.Movie S2. Imaging Activity-Dependent Lysosomal Fusion Using LAMP2-SEP, Related to Figure 5Sample video clip from experiments shown in Figure 5B. A dissociated hippocampal neuron (soma on the top left) was transfected with LAMP2-SEP (green fluorescence). The experiment starts with a period of photobleaching (denoted by the label "photobleach" on the top right corner of the clip), in order to eliminate baseline fluorescence of LAMP-2 that is already present on the cell surface. Following photobleaching, there is a baseline recording, after which the culture is stimulated with 45 mM K^+^ (denoted by the label "K^+^" on the top right corner of the clip). During stimulation, there is a rapid emergence of fluorescence puncta throughout the dendritic arbour, which are not seen during baseline imaging. Frames were acquired at the rate of 1/s and are played at a rate of 4/s.Document S2. Article plus Supplemental Information
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![Lysosomes Contribute to bpAP-Evoked Dendritic Ca^2+^ Signaling\
(A) Top: CA1 neuron loaded with Alexa 488 (green) and stained with LysoTracker (red) (scale bar, 10 μm). Disruption of the lysosomal membrane with GPN abolished LysoTracker staining. Regions of interest (white boxes) are magnified below (scale bar, 2 μm).\
(B) Average LysoTracker staining in ACSF (artificial cerebrospinal fluid) and GPN (n = 5 cells/condition). Significance was assessed with a Mann-Whitney test.\
(C) Example bpAP-evoked Ca^2+^ transient in CA1 apical dendrites loaded with OGB-1 (scale bar, 10 μm). Laser scanning was restricted to a line across a region of interest (circle). The resulting line scan (scale bar, 50 ms), along with its quantification (%ΔF/F) is shown time-locked with electrophysiological recordings. GPN reduced the bpAP-evoked Ca^2+^ influx.\
(D) CA1 neuron loaded with OGB-1. Ca^2+^ transients evoked before (black traces) and after (red traces) the addition of GPN are shown for regions of interest (scale bar, 20 μm).\
(E) Average data (n = 7--18 cells/condition).\
Significance was assessed with Kruskal-Wallis and post hoc Dunn's tests. Error bars represent SEM. See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![Lysosomal Ca^2+^ Release Requires NAADP\
(A--D) Left: sample Ca^2+^ transients evoked by single bpAPs in CA1 apical dendrites. Ca^2+^ transients were reduced following inhibition of lysosomal Ca^2+^ signaling by various reagents. Right: average peak Ca^2+^ signal measured across conditions (n = 5--10 cells/condition). Significance was assessed with Mann-Whitney tests (single comparisons) or Kruskal-Wallis and post hoc Dunn's tests (multiple comparisons).\
(E) Left: example of line scan images (scale bar, 100 ms) and quantified traces (%ΔF/F) of Ca^2+^ signals recorded in CA1 apical dendrites in acute hippocampal slices. Right: average peak fluorescence (n = 6--7 cells/condition). Ca^2+^ transients were reduced by GPN and NED-19. Significance was assessed with Kruskal-Wallis and post hoc Dunn's tests.\
Error bars represent SEM. See also [Figures S1--S5](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![Ca^2+^ Influx through VGCCs Triggers Lysosomal Ca^2+^ Release\
(A) Example line scan images (scale bar, 100 ms) and quantified traces (%ΔF/F) of bpAP-evoked Ca^2+^ transients in CA1 apical dendrites (scale bar, 10 μm) time-locked to electrophysiological recordings. Ni^2+^ and Cd^2+^ abolished Ca^2+^ influx evoked either by a single bpAP or a 200-ms step depolarization to \>20 mV.\
(B) Average data. Ca^2+^ transients were abolished by inhibition of VGCC-mediated Ca^2+^ influx by Ni^2+^/Cd^2+^ or 0 Ca^2+^ and did not significantly differ from transients recorded in the absence of stimulation (no stim. control) (n = 5--6 cells/condition).\
(C) Sample bpAP-evoked Ca^2+^ transients shown before and after the presence of ryanodine or thapsigargin to inhibit Ca^2+^ signaling from the ER.\
(D) Average peak Ca^2+^ transients. Inhibition of ER or mitochondrial Ca^2+^ signaling (FCCP) had no effect on bpAP-evoked Ca^2+^ transients and failed to occlude the effects of GPN (n = 3--5 cells/condition).\
Significance was assessed with paired t tests (single paired comparisons) or Kruskal-Wallis and post hoc Dunn's tests (multiple comparisons). Error bars represent SEM. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![Lysosomal Ca^2+^ Signaling Drives Fusion of the Lysosomes with the Plasma Membrane\
(A) Top: TIRFM images of a dissociated hippocampal neuron loaded with LysoTracker. K^+^ stimulation resulted in translocation of LysoTracker-stained puncta to the cell surface (scale bar, 10 μm). The imaged area in the yellow box is magnified below (scale bar, 5 μm). Bottom: average change in LysoTracker fluorescence across time (n = 5 cells/condition). K^+^-induced increases in fluorescence were abolished by NED-19. Time-dependent decreases in fluorescence reflected photobleaching. Significance was assessed with Mann-Whitney test at the peak of fluorescence.\
(B) Sample TIRFM images of individual LysoTracker-stained puncta in (A) (scale bar, 2 μm). Graphs depict fluorescence intensity in AFU against time.\
(C) Schematic of live-cell immunolabeling of LAMP-2. Fluorescently tagged antibodies targeting the lumenal domain of LAMP-2 were applied to neuronal cultures during K^+^ stimulation. Fluorescent labeling would require fusion of the lysosome with the plasma membrane.\
(D) Left: sample images depicting surface LAMP-2 antibody labeling in dissociated hippocampal cultures (scale bar, 10 μm). Labeling in K^+^-treated cultures was greater than under control conditions. Right: the graph depicts group averages of LAMP-2 labeling (n = 10--23 cells/condition). NED-19 and bafilomycin prevented activity-dependent increases in LAMP-2 labeling.\
Significance was assessed with Kruskal-Wallis and post hoc Dunn's tests. Error bars represent SEM. See also [Figure S6](#mmc1){ref-type="supplementary-material"} and [Movie S1](#mmc2){ref-type="supplementary-material"}.](gr4){#fig4}

![Imaging Lysosomal Fusion with LAMP2-SEP\
(A) Schematic of LAMP2-SEP. pH-dependent changes in fluorescence were used to monitor lysosomal fusion.\
(B) TIRFM image of a dissociated hippocampal neuron transfected with LAMP2-SEP (scale bar, 10 μm). The imaged area in the yellow box is magnified below (scale bar, 5 μm).\
(C and D) Average K^+^-evoked changes in LAMP2-SEP fluorescence in time (D, n = 5--7 cells/condition) with peak changes quantified in (D). Activity-dependent increases in fluorescence were abolished by NED-19 or intracellular loading of Syt7.\
(E) Schematic of the experiment using the alkaline trap to examine lysosome fusion in response to bpAPs. Neurons were stimulated with 300 action potentials at 5 Hz in the presence of bafilomycin to prevent re-acidification of the lysosome upon internalization.\
(F) Confocal image of a dissociated neuron transfected with LAMP2-SEP (scale bar, 10 μm). The imaged area in the yellow box is magnified below (scale bar, 5 μm). bpAPs triggered an increase in fluorescence.\
(G) Average bpAP-evoked change in LAMP2-SEP fluorescence (n = 6--7 cells/condition). No activity-dependent increases in fluorescence occurred following extracellular application of NED-19 or intracellular loading of Syt7.\
Significance was assessed with Kruskal-Wallis and post hoc Dunn's tests. Error bars represent SEM. See also [Figure S7](#mmc1){ref-type="supplementary-material"} and [Movie S2](#mmc3){ref-type="supplementary-material"}.](gr5){#fig5}

![Lysosomal Fusion Results in the Release of Cathepsin B, which Activates MMP-9 Signaling\
(A) Confocal image of a dissociated hippocampal neuron (scale bar, 10 μm) loaded with Magic Red Cathepsin B fluorogenic substrate (red) and LysoTracker (green). The dendrite in the white box is magnified below (scale bar, 5 μm) Cathepsin B-associated fluorescence co-localized with LysoTracker-labeled puncta (yellow). Application of 45 mM K^+^ resulted in de-staining of some of the imaged puncta (yellow arrowheads), consistent with lysosomal fusion and loss of Cathepsin B activity.\
(B) Activity-dependent change in Cathepsin B-associated fluorescence of imaged puncta across experiments (n = 152--254 puncta from 5--6 cells/condition). The dashed line marks 3 SD from average fluorescent changes recorded in unstimulated controls (no stim.). Significance was assessed with Kruskal-Wallis and post hoc Dunn's tests.\
(C) Fraction of Cathepsin B puncta undergoing fusion, as defined by a fluorescence loss of \>3 SD (dashed line in B). NED-19 prevented activity-dependent loss of Cathepsin B activity. Significance was assessed with z tests (Bonferroni correction).\
(D) Extracellular Cathepsin B expression levels in hippocampal slices measured using ELISA (n = 5--7 slices/condition). Activity was stimulated by elevating extracellular K^+^ to 30 mM. Activity-dependent increases in Cathepsin B secretion were abolished with NED-19.\
(E) Extracellular Cathepsin B activity levels measured in hippocampal slices using the fluorogenic Cathepsin B substrate Z-Arg-Arg-AMC (n = 5 slices/condition). Activity-dependent increases in Cathepsin B activity were abolished by NED-19.\
(F) Average MMP activity in hippocampal slices measured using an MMP fluorogenic substrate (n = 12--29 slices/condition). Cathepsin B inhibition with CA-074 reduced MMP signaling in an activity-dependent manner.\
(G) Average MMP-9 fluorogenic activity in hippocampal slices (n = 5--14 slices/condition; [Experimental Procedures](#sec4){ref-type="sec"}). MMP-9 activity was driven by K^+^ stimulation and abolished by NED-19 and CA-074. Significance was assessed with ANOVA and post hoc Bonferroni tests.\
Error bars represent SEM. See also [Figures S8](#mmc1){ref-type="supplementary-material"} and [S9](#mmc1){ref-type="supplementary-material"}.](gr6){#fig6}

![Cathepsin B Release Is Necessary for MMP-9-Mediated Long-Lasting Structural Plasticity\
(A) Schematic of the experiment. Glutamate photolysis at a target spine was paired with bpAPs to induce long-lasting structural plasticity.\
(B--D) Left: sample images of CA1 dendritic spines (scale bars, 1 μm). Images of target (yellow arrow) and neighboring spines are shown at −2.5, +1, +30, and +60 min following paired stimulation. Right: average change in spine volume of target and neighboring spines across time (n = 5--9 cells/condition). Long-lasting structural plasticity was abolished by inhibiting lysosomal function with NED-19, desensitizing concentrations of NAADP, or intracellular loading of Syt7 (B). Structural plasticity was also abolished by inhibiting Cathepsin B activity with CA-074 (C). Bath application of either active Cathepsin B (C) or active MMP-9 (D) for 10 min after the start of paired stimulation rescued long-lasting structural plasticity. Neighboring spines remained unchanged across experimental conditions.\
(E) Average change in spine volume at 60 min post-pairing for target and neighboring spines (n = 5--9 cells/condition).\
Significance was assessed with Kruskal-Wallis and post hoc Dunn's tests. Asterisks denote the significant differences (p \< 0.05) from control conditions. All other comparisons with control groups are not significant. Error bars represent SEM.](gr7){#fig7}

![Proposed Model\
(A) 1: bpAPs activate dendritic VGCCs. 2: VGCC-mediated Ca^2+^ influx triggers Ca^2+^ release from the lysosome via an NAADP-sensitive channel. 3: lysosomal Ca^2+^ release triggers fusion of the lysosome with the plasma membrane, resulting in the release of Cathepsin B. 4: Cathepsin B cleaves TIMP-1, releasing MMP-9 from inhibition. 5: MMP-9 activity maintains the long-lasting structural plasticity of dendritic spines.\
(B) Targets of pharmacological reagents used in this study.](gr8){#fig8}
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